Marshall Wace’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$76.7M Buy
521,200
+398,400
+324% +$64.8M 0.08% 237
2025
Q4
$23.9M Buy
122,800
+23,700
+24% +$5.64M 0.02% 572
2025
Q3
$27.9M Buy
99,100
+58,300
+143% +$14.8M 0.03% 518
2025
Q2
$8.92M Buy
40,800
+38,900
+2,047% +$6.28M 0.01% 892
2025
Q1
$266K Buy
+1,900
New +$309K ﹤0.01% 2309
2024
Q4
Sell
-400
Closed -$68.2K 2895
2024
Q3
$68.2K Sell
400
-70,600
-99% -$10.2M ﹤0.01% 2402
2024
Q2
$10M Buy
+71,000
New +$8.82M 0.01% 731
2024
Q1
Sell
-46,600
Closed -$4.91M 2709
2023
Q4
$4.91M Sell
46,600
-27,200
-37% -$2.97M 0.01% 922
2023
Q3
$7.82M Buy
73,800
+27,000
+58% +$3.13M 0.02% 725
2023
Q2
$5.57M Buy
46,800
+21,200
+83% +$2.19M 0.01% 968
2023
Q1
$2.38M Sell
25,600
-53,200
-68% -$4.67M 0.01% 1364
2022
Q4
$6.44M Sell
78,800
-92,500
-54% -$7.03M 0.01% 1032
2022
Q3
$10.5M Buy
+171,300
New +$12.5M 0.02% 853
2021
Q4
Sell
-74,000
Closed -$6.45M 4181
2021
Q3
$6.45M Buy
+74,000
New +$6.54M 0.03% 800

Other funds holding ORCL

Marshall Wace's ORCL Position: Q1 2026 in Review

Marshall Wace increased its Oracle (ORCL) stake by 31% in Q1 2026, buying an estimated $22.6M and bringing the position to 588,225 shares worth $86.5M. The position accounts for 0.09% of the portfolio, ranked #203.

Marshall Wace first reported a position in ORCL in Q3 2014 and has held it in 35 quarters since. The position peaked at $353M in Q1 2024. 3,472 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Marshall Wace held 588,225 shares of Oracle worth $86.5M as of Q1 2026.
  • Marshall Wace bought 138,986 Oracle shares in Q1 2026, an estimated $22.6M.
  • Oracle made up 0.09% of Marshall Wace's portfolio in Q1 2026, its #203 holding.
  • Marshall Wace first reported a position in Oracle in Q3 2014 and has held it in 35 quarters since.
  • Marshall Wace's Oracle position peaked at $353M in Q1 2024.
  • 3,472 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.